Neurotrophin Signaling in the Human Trabecular Meshwork
Principal Investigator
Robert Wordinger, PhD
University of North Texas Health Science Center
Fort Worth, TX, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$47,026
Active Dates
April 01, 1999 - March 31, 2001
Grant ID
G1999017
Summary
The trabecular meshwork is an intricate system of drainage canals through which the intraocular fluid, also called the aqueous humor, drains from the eye. This drainage helps the eye maintain normal fluid pressure. Dr. Wordinger has hypothesized that a certain class of growth factors, called neurotrophins, play an important role in cells of the trabecular meshwork (TM). He hopes to improve our knowledge of the normal physiology of aqueous humor outflow via the TM and to determine if neurotrophins play a role in glaucoma. If the latter proves to be true, existing compounds for regulating neurotrophins can be tested for their therapeutic value.
Related Grants
National Glaucoma Research
Exploring Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Qi Cui, MD, PhD
Current Organization
University of Pennsylvania, Perelman School of Medicine
Exploring Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Qi Cui, MD, PhD
Current Organization
University of Pennsylvania, Perelman School of Medicine
National Glaucoma Research
Measuring the Effects of Visual Stimuli on Retinal Blood Vessels and Flow
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Stuart Gardiner, PhD
Current Organization
Good Samaritan Foundation, Legacy Health System
Measuring the Effects of Visual Stimuli on Retinal Blood Vessels and Flow
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Stuart Gardiner, PhD
Current Organization
Good Samaritan Foundation, Legacy Health System
National Glaucoma Research
Reducing Inflammation to Protect Vision in Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Cátia Gomes, PhD
Current Organization
Indiana University School of Medicine
Reducing Inflammation to Protect Vision in Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Cátia Gomes, PhD
Current Organization
Indiana University School of Medicine